What Happened to Bodycote plc Shares on 13 November 2026?

Bodycote plc (LSE:BOY) shares eased 0.16% to 918.5p on 13 November 2026. The thermal processing group was in focus after publishing its 2026 interim results on 28 July 2026.

The update reported results in line with expectations, Margin progress and an unchanged full-year outlook.

Bodycote has a long record of operating in thermal processing and describes itself as a global leader in the field. Its sites are located close to customers in North America, Europe and Asia, which supports reliable delivery of services.

Key Highlights

Group Revenue rose 3.3% to £381.2m and adjusted operating profit rose 10.7% to £61.0m, with the adjusted Operating Margin improving 110 basis points to 16.0%. Core revenue was £372.0m, with organic growth of 9.6%.

Adjusted Basic Earnings Per Share rose 18.3% to 25.2p, and the Interim Dividend rose 4.3% to 7.2p.

About Bodycote plc

Bodycote is a global provider of heat treatment and specialist thermal processing services. Its customers operate in aerospace and defence, energy, medical, automotive and general industrial markets.

The group reports through two core divisions, Specialist Technologies and Precision Heat Treatment.

Specialist Technologies

Revenue in Specialist Technologies was £121.2m, up 16.7% organically, with adjusted operating profit of £31.6m and an adjusted operating margin of 26.1%. The division serves demanding applications in sectors such as aerospace.

It earns almost as much operating profit as the larger Precision Heat Treatment division on around half the revenue.

Precision Heat Treatment

Precision Heat Treatment revenue was £250.8m, up 6.4% organically, with adjusted operating profit of £37.6m and a margin of 15.0%. The division provides heat treatment services across a wide range of industrial applications.

Good growth was reported across the group's target end markets.

End Markets

Management cited Demand from aerospace and defence, industrial gas turbines, medical and semiconductor-related markets. Energy revenue rose 4.7%, with industrial gas turbine revenue up more than 10%.

Full-year core organic revenue growth is expected to be led by aerospace and defence, industrial gas turbines and medical.

Optimise Programme

The Optimise programme restructures the group's network and improves efficiency, with further benefits of around £2m delivered in the first half. Non-core revenue has reduced as part of the programme.

Management said it expects further strategic progress in the second half and remains confident in its mid-term targets.

Understanding Core and Organic Growth

Core results exclude non-core sites included in the Optimise programme, so they show the performance of the businesses the group intends to keep. Organic growth excludes the effect of currency and acquisitions or disposals.

Adjusted operating margin shows operating profit before specific items as a share of revenue.

Why the Update Matters for the Sector

Industrial service providers are followed for how they combine Volume growth with efficiency programmes. Bodycote's results show how a mix shift towards specialist technologies can influence margins.

The spread of end markets also provides a view of demand across aerospace, energy and medical industries.

Customers and Applications

Bodycote's services improve the strength, durability and performance of metal components used in demanding settings, including aircraft parts, power generation equipment and medical implants. Customers rely on the group's technical expertise and global site network.

The group operates a large network of facilities, which allows it to serve customers close to where components are made.

Key Growth Catalysts

Specialist Technologies growth, aerospace and defence demand and further Optimise benefits give the group several routes to support earnings. A diversified end-market mix provides breadth.

Factors to Monitor

Industrial demand can vary with economic conditions, and the pace of growth in the second half is influenced by prior-year comparators. Energy costs and currency movements also affect results.

What Investors Should Watch Next

Investors may wish to follow second-half core organic growth, margin progress, Optimise benefits and the full-year results.

Conclusion

Bodycote plc (LSE:BOY) eased 0.16% to 918.5p on 13 November 2026. Bodycote reported 9.6% core organic revenue growth, a 110 basis point margin improvement and an unchanged full-year outlook. Full-year results are the next detailed update.